amelia morrone
associated professor
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Articles (13)
Gaucher disease (GD) is a rare genetic metabolic disorder characterized by a dysfunction of the lysosomal glycoside hydrolase glucocerebrosidase (GCase) due to mutations in the gene GBA1, leading to the cellular accumulation of glucosylceramide (GlcCer). While most of the current research focuses on the primary accumulated material, lesser attention has been paid to secondary storage materials and their reciprocal intertwining. By using a novel approach based on flow cytometry and fluorescent labelling, we monitored changes in storage materials directly in fibroblasts derived from GD patients carrying N370S/RecNcil and homozygous L444P or R131C mutations with respect to wild type. In L444P and R131C fibroblasts, we detected not only the primary accumulation of GlcCer accumulation but also a considerable secondary increase in GM1 storage, comparable with the one observed in infantile patients affected by GM1 gangliosidosis. In addition, the ability of a trivalent trihydroxypiperidine iminosugar compound (CV82), which previously showed good pharmacological chaperone activity on GCase enzyme, to reduce the levels of storage materials in L444P and R131C fibroblasts was tested. Interestingly, treatment with different concentrations of CV82 led to a significant reduction in GM1 accumulation only in L444P fibroblasts, without significantly affecting GlcCer levels. The compound CV82 was selective against the GCase enzyme with respect to the β-Galactosidase enzyme, which was responsible for the catabolism of GM1 ganglioside. The reduction in GM1-ganglioside level cannot be therefore ascribed to a direct action of CV82 on β-Galactosidase enzyme, suggesting that GM1 decrease is rather related to other unknown mechanisms that follow the direct action of CV82 on GCase. In conclusion, this work indicates that the tracking of secondary storages can represent a key step for a better understanding of the pathways involved in the severity of GD, also underlying the importance of developing drugs able to reduce both primary and secondary storage-material accumulations in GD.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2020
Year:
2020
Collaborators (22)
Elena Barbieri
Associated Professor in Applied Biology
Università degli Studi di Udine
Laura Rapisarda
University of Catania
Carlo Dionisi-Vici
Head of the Division
Ospedale Pediatrico Bambino Gesù
Paolo Paoli
Associate Professor
University of Florence
Martina Cacciarini
-
Damiana Pieragostino
University of Chieti-Pescara
Macarena Martínez-Bailén
-
Claudia Rossi
Assistant Professor in Molecular Biology
University of Chieti-Pescara
Giulia Frisso
University of Naples Federico II
Margherita RUOPPOLO
University of Naples Federico II
FRANCESCA NARDECCHIA
Sapienza University of Rome
Gaetano Bertino
Associate Professor of Gastroenterology
University of Catania
Ines Bucci
University of Chieti-Pescara
Rita Barone
University of Catania
Vilberto Stocchi
Professore
University of Urbino
Francesca Cardona
-
Martino Calamai
University of Florence
Pierandrea Lo Nostro
University of Florence
alessandro salina
Istituto Giannina Gaslini
Camilla Matassini
-
Matteo Lulli
University of Florence
Alberto B. Burlina
-
Make your next move.
Prepare your application
Review drafts before you send them.